Study to Compare 2 Formulations of LY900014 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus
- Status
- TERMINATED
- Phase
- PHASE3
Study of LY3154207 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3316531 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3209590 in Japanese Participants With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3322207 in Healthy Participants and in Participants With Hypertension (High Blood Pressure)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Lasmiditan in Healthy Japanese and Caucasian Participants
- Status
- COMPLETED
- Phase
- PHASE1
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
- Status
- RECRUITING
- Phase
- N/A
Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care
- Status
- COMPLETED
- Phase
- NA
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Insulin Glargine (LY2963016) in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Expanded Access Program for AM0010 (Pegilodecakin)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A